Checkpoint Therapeutics Announces Encouraging Safety and Efficacy Data from Phase 1/2 Clinical Trial of EGFR Inhibitor CK-101
FinEx Metals Announces Exploration Program for its 100%-owned Kero Project in the Central Lapland Greenstone Belt, Finland
Lexaria Attending the BIO International Convention, as Part of a Broader Business Development Program
